Lineage Cell Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LCTX and other ETFs, options, and stocks.

About LCTX

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery.

CEO

Brian M. Culley

CEOBrian M. Culley

Employees

Employees77

Headquarters

Carlsbad, California

HeadquartersCarlsbad, California

Founded

1990

Founded1990

Employees

Employees77

LCTX Key Statistics

Market cap

111.51M

Market cap111.51M

Price-Earnings ratio

-5.81

Price-Earnings ratio-5.81

Dividend yield

—

Dividend yield—

Average volume

818.93K

Average volume818.93K

High today

$0.4944

High today$0.4944

Low today

$0.463

Low today$0.463

Open price

$0.47

Open price$0.47

Volume

891.14K

Volume891.14K

52 Week high

$1.15

52 Week high$1.15

52 Week low

$0.3651

52 Week low$0.3651

Analyst ratings

86%

of 7 ratings

Buy

85.7%

Hold

14.3%

Sell

People also own

Based on the portfolios of people who own LCTX. This list is generated using Robinhood data, and it’s not a recommendation.